C. David Klingman, PhD

Articles by C. David Klingman, PhD

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients

BySayeed Ikramuddin, MD,C. David Klingman, PhD,Therese Swan, BA,Michael E. Minshall, MPH

September 7th 2009

A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.

Latest Updated Articles

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
September 7th 2009

C. David Klingman, PhD

Articles by C. David Klingman, PhD

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access